Possessing commercial quantity of psychotropic drugs is

Image
Press Trust of India Madurai
Last Updated : Mar 23 2016 | 7:02 PM IST
The Madras High Court has ruled that possession of commercial quantity of psychotropic drugs by people who are neither importers nor exporters or manufacturers is punishable under Narcotic Drugs and Psychotropic Substances Act.
Justice P N Prakash of the court's Madurai bench gave the ruling while dismissing the bail pleas of Sankareswaran and Kaliyugakannan from whom the Narcotics Control Bureau seized 7.22 kg of Alprazolam (a sleep inducing drug given for blood pressure patients) at Thalavaipuram bus stand in Virudhunagar district.
"They are neither importers nor exporters or manufacturers to possess commercial quantity of the drug. Alprazolam is a psychotropic substance under section 22 of NDPS Act, and they could possess it only if they had a licence for import or export or manufacture," the judge said.
The Act empowered the central government to fix the small and commercial quantity of any drug, both Narcotic and Psychotrophic substance for purpose of deciding the quantum of punishment on conviction by court.
"In this case, the petitioners possessed 7.22 kg of Alprazolam, which was commercial quantity. Therefore, punishable with minimum sentence of ten years," the court observed.
Referring to an earlier judgment of the court that if the contraband was Alprazolam, then it would not attract the NDPS Act for punishment, the judge said the 2007 judgment ignoring the description of small quantity and commercial quantity was undoubtedly Per Incuriam (through lack of care).
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 23 2016 | 7:02 PM IST

Next Story